Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19188680rdf:typepubmed:Citationlld:pubmed
pubmed-article:19188680lifeskim:mentionsumls-concept:C0684249lld:lifeskim
pubmed-article:19188680lifeskim:mentionsumls-concept:C0796392lld:lifeskim
pubmed-article:19188680lifeskim:mentionsumls-concept:C0008838lld:lifeskim
pubmed-article:19188680lifeskim:mentionsumls-concept:C0045093lld:lifeskim
pubmed-article:19188680lifeskim:mentionsumls-concept:C0282461lld:lifeskim
pubmed-article:19188680lifeskim:mentionsumls-concept:C1696465lld:lifeskim
pubmed-article:19188680lifeskim:mentionsumls-concept:C1708063lld:lifeskim
pubmed-article:19188680pubmed:issue8lld:pubmed
pubmed-article:19188680pubmed:dateCreated2009-3-9lld:pubmed
pubmed-article:19188680pubmed:abstractTextBevacizumab, a monoclonal antibody targeting vascular endothelial growth factor, improves survival when combined with carboplatin/paclitaxel for advanced nonsquamous non-small-cell lung cancer (NSCLC). This randomized phase III trial investigated the efficacy and safety of cisplatin/gemcitabine (CG) plus bevacizumab in this setting.lld:pubmed
pubmed-article:19188680pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19188680pubmed:languageenglld:pubmed
pubmed-article:19188680pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19188680pubmed:citationSubsetIMlld:pubmed
pubmed-article:19188680pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19188680pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19188680pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19188680pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19188680pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19188680pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19188680pubmed:statusMEDLINElld:pubmed
pubmed-article:19188680pubmed:monthMarlld:pubmed
pubmed-article:19188680pubmed:issn1527-7755lld:pubmed
pubmed-article:19188680pubmed:authorpubmed-author:RamlauRodrygRlld:pubmed
pubmed-article:19188680pubmed:authorpubmed-author:ZatloukalPetr...lld:pubmed
pubmed-article:19188680pubmed:authorpubmed-author:ManegoldChris...lld:pubmed
pubmed-article:19188680pubmed:authorpubmed-author:HirshVeraVlld:pubmed
pubmed-article:19188680pubmed:authorpubmed-author:ReckMartinMlld:pubmed
pubmed-article:19188680pubmed:authorpubmed-author:von...lld:pubmed
pubmed-article:19188680pubmed:authorpubmed-author:LeighlNatasha...lld:pubmed
pubmed-article:19188680pubmed:authorpubmed-author:GorbounovaVer...lld:pubmed
pubmed-article:19188680pubmed:authorpubmed-author:MezgerJörgJlld:pubmed
pubmed-article:19188680pubmed:authorpubmed-author:ArcherVeniceVlld:pubmed
pubmed-article:19188680pubmed:authorpubmed-author:MooreNicolaNlld:pubmed
pubmed-article:19188680pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19188680pubmed:day10lld:pubmed
pubmed-article:19188680pubmed:volume27lld:pubmed
pubmed-article:19188680pubmed:ownerNLMlld:pubmed
pubmed-article:19188680pubmed:authorsCompleteYlld:pubmed
pubmed-article:19188680pubmed:pagination1227-34lld:pubmed
pubmed-article:19188680pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:19188680pubmed:meshHeadingpubmed-meshheading:19188680...lld:pubmed
pubmed-article:19188680pubmed:meshHeadingpubmed-meshheading:19188680...lld:pubmed
pubmed-article:19188680pubmed:meshHeadingpubmed-meshheading:19188680...lld:pubmed
pubmed-article:19188680pubmed:meshHeadingpubmed-meshheading:19188680...lld:pubmed
pubmed-article:19188680pubmed:meshHeadingpubmed-meshheading:19188680...lld:pubmed
pubmed-article:19188680pubmed:meshHeadingpubmed-meshheading:19188680...lld:pubmed
pubmed-article:19188680pubmed:meshHeadingpubmed-meshheading:19188680...lld:pubmed
pubmed-article:19188680pubmed:meshHeadingpubmed-meshheading:19188680...lld:pubmed
pubmed-article:19188680pubmed:meshHeadingpubmed-meshheading:19188680...lld:pubmed
pubmed-article:19188680pubmed:meshHeadingpubmed-meshheading:19188680...lld:pubmed
pubmed-article:19188680pubmed:meshHeadingpubmed-meshheading:19188680...lld:pubmed
pubmed-article:19188680pubmed:meshHeadingpubmed-meshheading:19188680...lld:pubmed
pubmed-article:19188680pubmed:meshHeadingpubmed-meshheading:19188680...lld:pubmed
pubmed-article:19188680pubmed:meshHeadingpubmed-meshheading:19188680...lld:pubmed
pubmed-article:19188680pubmed:year2009lld:pubmed
pubmed-article:19188680pubmed:articleTitlePhase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil.lld:pubmed
pubmed-article:19188680pubmed:affiliationDepartment of Thoracic Oncology, Hospital Grosshansdorf, Wohrendamm 80, 22927 Grosshansdorf, Germany. dr.martin.reck@web.delld:pubmed
pubmed-article:19188680pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19188680pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:19188680pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:19188680pubmed:publicationTypeClinical Trial, Phase IIIlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19188680lld:pubmed